Seneffe - Belgium, March 23, 2017 - Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) announces today that its annual financial report for the year ending December 31, 2016 is now available on the company`s website: http://www.bebig.com/home/investors/financial_reports/
Financial Calendar 2017: Annual General Meeting: June 8th, 2017 (11:30 am) Half-Year Results 2017: August 2nd, 2017
The results and trading updates will be published before market opens on the respective dates.
Eckert & Ziegler BEBIG ...Contributing to saving lives! Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treatment of cancer using brachytherapy. The company headquarters are in Belgium, with production facilities in Germany and in the USA, as well as subsidiaries throughout Europe, the USA, India and Brazil. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents, to support the international marketing and distribution of its product line. The company's products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists. Eckert & Ziegler BEBIG employs approximately 100 people. The company has been listed on the Euronext stock exchange since April 1997. Contact : Investor Relations Tel.: +32 (0) 64 520 808 E-mail: ir@bebig.com
